Media Update: Dupixent® continues scientific leadership with late-breaking results showing reduced airway inflammation and mucus plugging in adults with uncontrolled moderate-to-severe asthma

https://ift.tt/5IzSWUl

 

from Sanofi - Aventis Groupe https://ift.tt/2LMWYdk
via IFTTT